Last study published in the journal He informed that inhibiting aggregation (Gapdh) could be a therapeutic goal for acute ischemic stroke (AIS). The stroke is the second main cause of death. The recombinant tissue plasminogen activator is one of the most effective AIS treatment methods, but it has limited acceptability and narrow therapeutic window (within […]